Intramuscular Where oral therapy is not feasible, injectable corticosteroid therapy, including triamcinolone acetonide injectable suspension is indicated for intramuscular use as follows: Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions.
From the U.S. FDA-approved label for Triamcinolone Acetonide. Full label: DailyMed.
Intramuscular Where oral therapy is not feasible, injectable corticosteroid therapy, including triamcinolone acetonide injectable suspension is indicated for intramuscular use as follows: Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. Gastrointestinal diseases: To tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis.
From the U.S. FDA-approved label for Triamcinolone Acetonide. Full label: DailyMed.
General NOTE: CONTAINS BENZYL ALCOHOL (see PRECAUTIONS). The initial dose of triamcinolone acetonide injectable suspension may vary from 2.5 mg to 100 mg per day depending on the specific disease entity being treated (see Dosage section below). However, in certain overwhelming, acute, life-threatening situations, administration in dosages exceeding the usual dosages may be justified and may be in multiples of the oral dosages.
Directions from the U.S. FDA-approved label for Triamcinolone Acetonide — your doctor or pharmacist may advise differently.
Triamcinolone acetonide injectable suspension is contraindicated in patients who are hypersensitive to any components of this product (see WARNINGS: General ). Intramuscular corticosteroid preparations are contraindicated for idiopathic thrombocytopenic purpura.
Excerpt from the U.S. FDA-approved label for Triamcinolone Acetonide. Talk to a pharmacist or doctor before use.
Serious Neurologic Adverse Reactions with Epidural Administration Serious neurologic events, some resulting in death, have been reported with epidural injection of corticosteroids (see WARNINGS: Neurologic ). Specific events reported include, but are not limited to, spinal cord infarction, paraplegia, quadriplegia, cortical blindness, and stroke. These serious neurologic events have been reported with and without use of fluoroscopy. The safety and effectiveness of epidural administration of corticosteroids have not been established, and corticosteroids are not approved for this use.
Warnings and precautions excerpt from the U.S. FDA-approved label for Triamcinolone Acetonide — not a complete list. Talk to a pharmacist or doctor before use.
(listed alphabetically under each subsection) The following adverse reactions may be associated with corticosteroid therapy: Allergic reactions: Anaphylaxis including death, and angioedema.
Excerpt from the U.S. FDA-approved label for Triamcinolone Acetonide — not a complete list. Talk to a pharmacist or doctor about side effects.
13 brands · 7 makers in the NepalDoc catalog — see the full Triamcinolone Acetonide guide →
Storage Store at controlled room temperature, 20°C to 25°C (68°F to 77°F); protect from temperatures below 20°C (68°F). Store vial in carton to protect from light.
Storage information from the U.S. FDA-approved label for Triamcinolone Acetonide.
What is ORO HEAL?
ORO HEAL 0.1%W/W GEL is a Triamcinolone Acetonide medicine made by Aadee Remedies Pvt. Ltd. It comes as 0.1%W/W GEL.
What is the generic name of ORO HEAL?
The generic name of ORO HEAL is Triamcinolone Acetonide.
Which brands of Triamcinolone Acetonide are available in Nepal?
13 brands of Triamcinolone Acetonide are listed in the NepalDoc catalog, from 7 makers — including Aurocort 10mg Injection, Kenacort 0.1%W/W TUBE, Kenacort 10mg Injection, Kenacort 40mg Injection, Lledercort 10mg Tablet, Mucoheal 0.1% Paste.
What are the side effects of Triamcinolone Acetonide?
(listed alphabetically under each subsection) The following adverse reactions may be associated with corticosteroid therapy: Allergic reactions: Anaphylaxis including death, and angioedema.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.
